Glaxo Is Testing Paxil on 7-Year-Olds Despite Well Known Suicide Risks
Despite the fact that children may be at highest risk of antidepressant-induced suicide, GlaxoSmithKline is testing Paxil on 7 to 18 year old Japanese children.
Despite the fact that children may be at highest risk of antidepressant-induced suicide, GlaxoSmithKline is testing Paxil on 7 to 18 year old Japanese children.
"The resulting frenzy of psychiatric diagnoses has damaged the credibility of everyone in the field."
“The way Dr. Punjwani treated Emilio Villamar and the manner in which these drugs were prescribed is a picture of everything that’s wrong with this industry and the relationship between doctors and pharmaceutical companies.”
“The age of American children being medicated with prescription psychiatric drugs is getting younger and more widespread every year.”
A large-scale Harvard meta-analysis published in the Journal of the American Medical Association, is the first ever to evaluate the relationship between different anticonvulsant drugs and the risk of suicide in for patients with diverse diagnoses: " the risk was derived from the specific drug that the patient was taking and not their underlying conditions."
Unlike patients in other fields of medicine, those who are designated mentally ill–or even declared to be "at risk" for mental illness in the future–are at once stigmatized and suffer losss of their autonomy.
An educator with an insightful sense of humor calls psychiatry’s proclivity to designate all manner of human behavior as pathological–an affront.
"For her last month of life, Kifuji overall prescribed 835 pills to Rebecca….If what Dr. Kifuji did in this case is the acceptable standard of care for children in Massachusetts, then there is something very wrong in this state."
"Among all the problematic suggestions for DSM5, the proposal for a "Psychosis Risk Syndrome" stands out as the most ill–conceived and potentially harmful." Allen Frances, MD
"Judith Warner’s book illustrates the perils of preferring stories to science."
"Her mother’s murder trial has been over for a couple of weeks now, but I’m still haunted by little Rebecca Riley."
"Anything you put in that book, any little change you make, has huge implications not only for psychiatry but for pharmaceutical marketing, research, for the legal system, for who’s considered to be normal or not, for who’s considered disabled," said Dr. Michael First, professor of psychiatry at Columbia University who edited the DSM4l but is not involved in the DSM5.